These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2862924)

  • 1. Topographic EEG changes with benzodiazepine administration in generalized anxiety disorder.
    Buchsbaum MS; Hazlett E; Sicotte N; Stein M; Wu J; Zetin M
    Biol Psychiatry; 1985 Aug; 20(8):832-42. PubMed ID: 2862924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of clorazepate on depressed mood in anxious patients.
    Zung WW
    J Clin Psychiatry; 1987 Jan; 48(1):13-4. PubMed ID: 2879832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depressive symptoms and intellectual functioning in anxiety patients treated with clorazepate.
    Fabre LF; Putman HP
    J Clin Psychiatry; 1988 May; 49(5):189-92. PubMed ID: 2896666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography assessment of effects of benzodiazepines on regional glucose metabolic rate in patients with anxiety disorder.
    Buchsbaum MS; Wu J; Haier R; Hazlett E; Ball R; Katz M; Sokolski K; Lagunas-Solar M; Langer D
    Life Sci; 1987 Jun; 40(25):2393-400. PubMed ID: 2884547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
    Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
    Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 2. EEG-tomography findings based on LORETA (low-resolution brain electromagnetic tomography).
    Saletu B; Anderer P; Wolzt M; Nosiska D; Assandri A; Noseda E; Nannipieri F; Saletu-Zyhlarz GM
    Neuropsychobiology; 2009; 59(2):110-22. PubMed ID: 19365151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind comparison of buspirone and clorazepate in anxious outpatients.
    Cohn JB; Bowden CL; Fisher JG; Rodos JJ
    Am J Med; 1986 Mar; 80(3B):10-6. PubMed ID: 2870640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EEG topography of response to visual stimuli in generalized anxiety disorder.
    Grillon C; Buchsbaum MS
    Electroencephalogr Clin Neurophysiol; 1987 Apr; 66(4):337-48. PubMed ID: 2435513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clorazepate and lorazepam: clinical improvement and rebound anxiety.
    Rickels K; Fox IL; Greenblatt DJ; Sandler KR; Schless A
    Am J Psychiatry; 1988 Mar; 145(3):312-7. PubMed ID: 2894175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of bedtime dosing of benzodiazepines: a placebo-controlled comparison of halazepam and clorazepate.
    Aden GC; O'Hair DE
    Clin Ther; 1980; 3(3):209-18. PubMed ID: 6109568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative anxiolysis with minimal sedation in elderly patients: bromazepam or clorazepate-dipotassium?
    Erb T; Sluga M; Hampl KF; Ummenhofer W; Schneider MC
    Acta Anaesthesiol Scand; 1998 Jan; 42(1):97-101. PubMed ID: 9527752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single daily dose treatment of anxiety with clobazam or dipotassium clorazepate.
    Wallis TD; Vallé-Jones JC; Craven JR; Hanks GW; Stonier PD
    Br J Clin Pharmacol; 1979; 7 Suppl 1(Suppl 1):123S-127S. PubMed ID: 35192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The chlorazepate test in anxiety-depressive states].
    Peyre F; Bourgeois M
    Ann Med Psychol (Paris); 1988; 146(7):655-62. PubMed ID: 2906229
    [No Abstract]   [Full Text] [Related]  

  • 14. Clorazepat in the treatment of anxiety-depression syndroms in neuroses.
    Florkowski A; Kocur J; Rydzynski Z; Duszyk S; Trendak W; Gruszczyński W
    Act Nerv Super (Praha); 1989 Apr; 31(1):26-7. PubMed ID: 2571217
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and physiological assessment of chlorazepate, diazepam and placebo in anxious neurotics.
    Lapierre YD
    Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):315-22. PubMed ID: 239907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Subjective evaluation of the effect of single test doses of phenazepam and placebo in patients with anxiety disorders: a relationship with objective pharmaco-electroencephalography characteristics].
    Neznamov GG; Bochkarev VK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(9):53-60. PubMed ID: 30335073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated sleep EEG analysis applied to the evaluation of drugs: illustration by study of clorazepate dipotassium.
    Smith JR; Karacan I; Keane BP; Yang M
    Electroencephalogr Clin Neurophysiol; 1976 Dec; 41(6):587-94. PubMed ID: 62653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of chlorazepate dipotassium (Tranxene) in the states of restlessness and agitation].
    Kiejna A; Kantorska-Janiec M; Małyszczak K
    Psychiatr Pol; 1997; 31(6):753-60. PubMed ID: 9515307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clorazepate: double blind crossover comparison of a single nightly dose with diazepam thrice daily in anxiety.
    Magnus RV; Dean BC; Curry SH
    Dis Nerv Syst; 1977 Oct; 38(10):819-21. PubMed ID: 20284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient acceptance as a factor in the effectiveness of treatment: an open assessment of potassium clorazepate ('Tranxene') and lorazepam in anxiety.
    Harris PG
    Curr Med Res Opin; 1974-1975; 2(10):664-8. PubMed ID: 4156290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.